A national treasure • The end-trade price increase of 100% in one year proves there is ample room to grow for Pientzehuang series • Acquisition of 51% equity of Longhui Pharmaceuticals to further enrich its product line and enhance overall competitiveness • Initiate with BUY and target price (TP) of RMB 548.2 Scarce product, production […]

Read more of this post